| 2021-11-23 | Sale | Aptevo Therapeutics Inc. APVO | 921,336 12.987% | $11.25 | $10.37M | -73.69% | ||
| 2021-11-22 | Sale | Aptevo Therapeutics Inc. APVO | 10 percent owner | 255,331 5.9122% | $7.03 | $1.8M | -30.86% | |
| 2021-11-19 | Sale | Aptevo Therapeutics Inc. APVO | 10 percent owner | 213,800 4.7422% | $7.59 | $1.62M | -38.63% | |
| 2021-11-18 | Sale | Aptevo Therapeutics Inc. APVO | 10 percent owner | 369,533 8.1153% | $8.34 | $3.08M | -44.69% | |
| 2020-11-06 | Aptevo Therapeutics Inc. APVO | 10 percent owner | 348,554 7.5668% | $22.73 | $7.92M | +8.23% | ||
| 2020-11-05 | Aptevo Therapeutics Inc. APVO | 10 percent owner | 1.25M 25.0765% | $18.78 | $23.5M | +20.82% | ||
| 2020-11-04 | Aptevo Therapeutics Inc. APVO | 10 percent owner | 1.27M 24.3464% | $14.34 | $18.27M | +50.91% | ||
| 2019-10-04 | Heron Therapeutics, Inc. HRTX | director | 571,428 0.3221% | $8.75 | $5M | +2.41% | ||
| 2018-09-12 | Sale | Heron Therapeutics, Inc. HRTX | 5.39M 7.0856% | $35.75 | $192.69M | -29.59% | ||
| 2018-03-29 | Heron Therapeutics, Inc. HRTX | 384,616 0.5598% | $26.00 | $10M | +8.51% | |||
| 2017-02-23 | Cyclacel Pharmaceuticals, Inc. CYCC | 10 percent owner | 134,200 3.3648% | $4.34 | $582,079 | -53.33% | ||
| 2017-01-19 | Heron Therapeutics, Inc. HRTX | 4.92M 8.5734% | $12.20 | $60M | +10.47% | |||
| 2015-06-10 | Heron Therapeutics, Inc. HRTX | 242,424 0.6699% | $24.75 | $6M | -11.71% | |||
| 2015-06-02 | Heron Therapeutics, Inc. HRTX | 64,790 0.2146% | $23.84 | $1.54M | +12.42% | |||
| 2015-06-01 | Heron Therapeutics, Inc. HRTX | 4,760 0.0121% | $19.30 | $91,868 | +6.98% | |||
| 2015-05-29 | Heron Therapeutics, Inc. HRTX | 230,450 0.7416% | $19.74 | $4.55M | +31.96% | |||
| 2014-06-25 | Heron Therapeutics, Inc. HRTX | 1.02M 4.2484% | $11.75 | $12M | -19.42% | |||
| 2010-01-14 | Sale | Vanda Pharmaceuticals Inc. VNDA | 10 percent owner | 109,800 0.3994% | $10.73 | $1.18M | -23.85% | |
| 2010-01-13 | Sale | Vanda Pharmaceuticals Inc. VNDA | 10 percent owner | 173,000 0.6206% | $10.54 | $1.82M | -23.56% | |
| 2010-01-12 | Sale | Vanda Pharmaceuticals Inc. VNDA | 10 percent owner | 54,838 0.2047% | $10.88 | $596,621 | -22.91% |